書籍詳細

第I部 MRSA篇

P.104 掲載の参考文献

• 1) Waldvogel F.A.:Staphylococcus aureus. Principles and Practice and of Infectious Diseases (Mandell G. L. et al) Churchill Livingstone:1489-1510, 1990.

• 2) Brumfitt W. et al.:Methicillin Resistant Staphylococcus aureus. New Engl. J. Med. 320:1188-1196, 1989.
  pubmed

• 3) Chambers H. F.:Methicillin Resistant Staphylococci. Clin. Microbiol. Rev. 1:173-186, 1988.
  pubmed

• 4) Boyce J. M.:Methicillin Resistant Staphylococcus aureus. Infectious Disease Clinics of North America. 3:901-914, 1989.
  pubmed

• 5) 菅野治重:細菌調査におけるMRSAの判定基準. 最新医学44:2510-2514, 1989.

• 6) Chambers H. F.:Treatment of Infection and Colonization caused by Methicillin Resistant Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 12:29-35, 1991.
  pubmed

• 7) Rahal J J.:Treatment of Methicillin Resistant Staphylococcal Infections. Antimicrobial Agents Annual 1:489-514, 1986.

• 8) 後藤 元ら:本邦における多剤耐性黄色ブドウ球菌の現況. Chemotherapy 37:1334-1341, 1989.

• 9) 小林寛伊:MRSA院内感染対策. 第93回日本医学会シンポジウム記録集. (日本医学会) 57-63, 1992.

• 10) 伊藤昌男:日米欧における抗菌薬の使用と開発状況. 最新医学44:2458-2465, 1989.

• 11) Mayhall C. G.:Methicillin Resistant S taphylococcus aureus. Infection Control, Plenum Press. 33-49, 1990.

• 12) Shanson D. C. et al.:Operating theatre acquired infection with a Gentamicin resistant strain of Staphylococcus aureus-Outbreaks in two hospitals attributable to one surgeon. J. of Hosp. Infection 1:171-172, 1980.

• 13) Valls V. et al.:Eflicacy of a Maintained Surveillance Program for Control of Multiple Antibiotic Resistant Staphylococcus aureus. Abstracts No 29 0f the 31st Intersci. Conf. Antimicrob. Agents Chemother. 1991.

• 14) Opal S. M. et al.:Frequent acquisition of Multiple Strains of Methicillin Resistant Staphylococcus aureus by Healthcare Workers in an Endemic Hospital Environment. Infect. Control. Hosp. Epidemiol. 11:479-485, 1990.

• 15) Cookson B. et al.:Staff Carriage of Epidemic Methicillin Resistant Staphylococcus aureus. J. Clin. Microbiol. 27:1471-1476, 1989.
  pubmed

• 16) Bradley S. F. et al.:Methicillin Resistant Staphylococcus aureus:Colonization and Infection in a Long term Care Facility. Ann. Int. Med. 115:417-422, 1991.

• 17) Muder R. R. et al.:Methicillin Resistant Staphylococcal Colonization and Infection in a Long-Term Care Facility. Ann. Int. Med. 114:107-112, 1991.

• 18) Myers J. P. et al.:Bacteremia due to Methicillin Resistant Staphylococcus aureus. J. Inf. Dis. 145:532-536, 1982.

• 19) Sorrell T. C. et al.:Vancomycin Therapy for Methicillin Resistant Staphylococcus aureus. Ann. Int. Med. 97:344-350, 1982.
  pubmed

• 20) Craven D. E. et al.:Vancomycin Treatment of Bacteremia Caused by Oxacillin Resistant Staphylococcus aureus:Comparison with βLactam Antibiotic Treatment of Bacteremia caused by Oxacillin Sensitive Staphylococcus aureus. J. Inf. Dis. 147:137-143, 1983.

• 21) 島川 馨, 砂川慶介ら:塩酸バンコマイシンの臨床成績. 第38日本化学療法学会東日本支部総会, 1991.

• 22) Kucers A. & Bennett N. Mck.:Vallcomycin, The Use of Antibiotics, Lippincott.:1045-1072, 1987.

• 23) Matzke G. R. et al.:Pharmacokinetics of Vancomycin in patients with various degrees of renal function. Antimicrob. Ag. Chemother. 25:433, 1984.

• 24) 南方 保ら:血液透析患者におけるVancomycin の血中動態と各種透析膜によるVancomycin の除去の検討:第 38 回日本化学療法学会東日本支部総会, 1991.

• 25) Gopal V. et al.:Failure of Vancomycin Treatment in Staphylococcus aureus Endocaraditis. JAMA 236:1604-1606, 1976.
  pubmed

• 26) Faville R. J. et al.:Staphylococcus aureus Endocarditis Combined Therapy with Vancomycin and Rifampin. JAMA. 240:1963-1965, 1978.
  pubmed

• 27) Swanberg L. et al.:Rifampin in the Treatment of Serious Staphylococcal Infections. Am. J. Med. Sci. 287:49-54, 1984.
  pubmed

• 28) 後藤美江子, 古川恵一ら:臨床分離株, S.aureusに対するST合剤の薬剤感受性. 第38回日本化学療法学会東日本支部総会, 1991.

• 29) Markowitz N. et al.:Comparative efficacy and toxicity of Trimethoprim-Sulfamethoxazole versus Vancomycin in the therapy of serious Staphylococcus aureus infection. Infersci. Conf. Antimicrob. Agents Chemother. Abstracts No 903, 1985.

• 30) Yeldandi V. et al.:In vitro and In vivo studies of Trimethoprim-Sulfamethoxazole against multiple resistant Staphylococcus aureus. J. of Antimicrobial Chemother. 22:873-880, 1988.
  pubmed

• 31) 古川恵一ら:ST合剤が有効であったMRSA感染症の11症例, 第40回日本化学療法学総会, 1992.

• 32) Clumeck N. et al.:Treatment of severe Staphylococcal infections with a Rifampicin-Minocycline association. J. Antimicrobial Chemotherapy. 13:Supple C. 17-22, 1984.

• 33) 古川恵一:米国臨床研修体験;理路整然とした感染症のチーム診療. 週刊医学界新聞1838号:3-4, 1989.

• 34) Bennett J. V.:Hospital Infection, Little, Brown, 1986.

• 35) Hampton A. A. et al.:Vascular access infections in hospitalized patients. Surg. Clin. North Am. 68:60, 1988.

• 36) Wenzel R. P. et al.:Methicillin Resistant Stappylococcus aureus; Implications for the 1990 s and Effective Control Measures. Am. J. Med. 91:3B, 221 S-227 S, 1991.

• 37) Boyce J. M.:Should We vigorously Try To Contain and Control Methicillin Resistant Staphylococcus aureus? Infect. Control Hosp. Epidemiol. 12:46-54, 1991.
  pubmed

• 38) Ribner B. S. et al.:Strict versus Modified Isolation for Prevention of Nosocomial Transmission of Methicillin Resistant Staphylococus aureus. Infect. Control 7 (6):317-320, 1986.

• 39) Proctor M. E. et al.:Recommendations for control of Methicillin Resistant Staphylococcus aureus in acute and extended care facilities and for the transfer between facilities of patients colonized with MRSA. State of Wisconsin, Department of Health and Social Services, 1991.

• 40) Haley C. E. et al.:Bactericidal Activity of Antiseptics Against Methicillin Resistant Staphylococcus aureus. J. Clin. Microbiol. 21:991-992, 1985.
  pubmed

• 41) Mupirocin-a new topical antibiotic. Med. Lett. Drugs Ther. May 20;30 (766):55 56, 1988.

• 42) Hill R. L. R. et al.:Elimination of nasal carriage of Methicillin Resistant Staphylococcus aureus with Mupirocin during a hospital outbreak. J. of Antimicrobial Chemother. 22:377-384, 1988. J. of Antimicrobial Chemother 18:Supple A,1-12, 1986.

• 43) Boelaert J. R. et al.:The influence of Calcium Mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol. Dial. Trallsplant. 4:278-281, 1989.
  pubmed

• 44) Rode H. et al.:Efficacy of Mupirocin Methicillin Resisntant Staphylococcus aureus burn wound infection. Antimicrob. Ag. Chemother. 33:1358-1361, 1989.

• 45) Cookson B. D.:Mupirocin resistance in Staphylococci. J. Antimicrob. Chemother. 25:497-503. 1990.
  pubmed

• 46) Roccaforte J. S. et al:Attempts to eradicate Methicillin Resistant Staphylococcus aureus colonization with the use of Trimethoprim-Sulfamethoxyzole, Rifampin, and Bacitracin. Am. J. Inf. Control, 16:141-146, 1988.

• 47) Maki D. G.:Strategies for Prevention of MRSA Infections. Update in Infectious Deseases, University of Wisconsinl. 1991. (Personal communications with Dr. Maki)